Live from the NIH registry
Studies recruiting near Chicago right now
Top 25 of 2,441 recruiting studies, sorted by proximity — each links to its official registry page
Nephrotic Syndrome Study Network
Minimal Change Disease (MCD), Membranous Nephropathy
N/A
Observational 1,200 participants sought
John Stroger Cook County Hospital — Chicago, Illinois (2.1 mi)
· Sponsor: University of Michigan
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
Ann & Robert H. Lurie Children's Hospital of Chicago (Adults and Pediatrics) — Chicago, Illinois (2.1 mi)
· Sponsor: Pierre Fabre Medicament
Combining MyoCI With Memory Reactivation to Improve Motor Recovery After Stroke
Stroke
N/A
Interventional 70 participants sought
Northwestern University — Chicago, Illinois (2.1 mi)
· Sponsor: Northwestern University
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Chronic Graft-versus-host-disease
Phase 2
Interventional 296 participants sought
The University of Chicago Medical Center (UCMC) — Chicago, Illinois (2.1 mi)
· Sponsor: Syndax Pharmaceuticals
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
High Grade Glioma, Diffuse Intrinsic Pontine Glioma
Phase 2
Interventional 120 participants sought
Ann & Robert H. Lurie Children's Hospital of Chicago — Chicago, Illinois (2.1 mi)
· Sponsor: Nationwide Children's Hospital
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Endometrial Cancer
Phase 2, Phase 3
Interventional 268 participants sought
Dr. Sudarshan K. Sharma, Ltd. — Hinsdale, Illinois (13.1 mi)
· Sponsor: Kartos Therapeutics, Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Lurie Children's Hospital-Chicago — Chicago, Illinois (2.1 mi)
· Sponsor: National Cancer Institute (NCI)
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
University Illinois Chicago — Chicago, Illinois (2.1 mi)
· Sponsor: Westat
Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated Assessment
Myasthenia Gravis, Neuromuscular Disease
N/A
Observational 1,000 participants sought
ZS Associates — Evanston, Illinois (14.1 mi)
· Sponsor: ZS Associates
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Ulcerative Colitis
Phase 2
Interventional 224 participants sought
University of Chicago Medical Center — Chicago, Illinois (2.1 mi)
· Sponsor: Genentech, Inc.
A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
Muscular Atrophy, Spinal
Phase 3
Interventional 30 participants sought
Ann and Robert H Lurie Childrens Hospital of Chicago — Chicago, Illinois (2.1 mi)
· Sponsor: Biogen
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Northwestern University — Chicago, Illinois (2.1 mi)
· Sponsor: Medtronic MiniMed, Inc.
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Multiple Myeloma
Phase 1
Interventional 127 participants sought
University of Chicago Medical Center /ID# 278863 — Chicago, Illinois (2.1 mi)
· Sponsor: AbbVie
Intralesional Gardasil-9 for the Treatment of Recalcitrant Warts
Warts, Verruca (Warts)
Phase 2
Interventional 55 participants sought
Rush University Medical Center — Chicago, Illinois (2.1 mi)
· Sponsor: Rush University Medical Center
One-Time DNA Study for Vasculitis
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Giant Cell Arteritis
N/A
Observational 1,000 participants sought
Northwestern University — Chicago, Illinois (2.1 mi)
· Sponsor: University of Pennsylvania
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Cancer Treatment Centers of America-Chicago — Chicago, Illinois (2.1 mi)
· Sponsor: American Society of Clinical Oncology
CLOZAPINE Response in Biotype-1
Schizophrenia, Schizoaffective Disorder
Phase 4
Interventional 524 participants sought
University of Chicago — Chicago, Illinois (2.1 mi)
· Sponsor: University of Texas Southwestern Medical Center
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
Prostate Cancer, Prostate Adenocarcinoma
Phase 2
Interventional 90 participants sought
University of Chicago Comprehensive Cancer Center — Chicago, Illinois (2.1 mi)
· Sponsor: University of Chicago
Impact of Virtual Reality on Anxiety in Patients Undergoing Interventional Procedures
Anxiety
N/A
Interventional 64 participants sought
Anesthesiology Pain Medicine Center — Chicago, Illinois (2.1 mi)
· Sponsor: Northwestern University
APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women
Overactive Bladder (OAB), Urinary Urgency
N/A
Interventional 596 participants sought
University of Chicago — Chicago, Illinois (2.1 mi)
· Sponsor: Medstar Health Research Institute
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Prostate Cancer
Phase 3
Interventional 940 participants sought
Northwestern University — Chicago, Illinois (2.1 mi)
· Sponsor: Novartis Pharmaceuticals
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Rush University Medical Center — Chicago, Illinois (2.1 mi)
· Sponsor: Relay Therapeutics, Inc.
Horizon Two: HR NDMM (MMRC-100)
High Risk Newly Diagnosed Multiple Myeloma
Phase 2
Interventional 300 participants sought
UChicago Medicine — Chicago, Illinois (2.1 mi)
· Sponsor: Multiple Myeloma Research Consortium
Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas
BRAF V600 Mutation, Low-grade Glioma
Phase 2
Interventional 96 participants sought
Ann & Robert H. Lurie Children's Hospital of Chicago — Chicago, Illinois (2.1 mi)
· Sponsor: University of California, San Francisco
A Study of Brenipatide in Participants With Alcohol Use Disorder
Alcohol Use Disorder
Phase 3
Interventional 1,100 participants sought
Re:Cognition Health - Chicago — Chicago, Illinois (2.1 mi)
· Sponsor: Eli Lilly and Company